These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Merkel cell carcinoma and immunosuppression: report of three cases and review of therapeutic options].
    Author: Gröger A, Piatkowski A, Unglaub F, Bozkurt A, Pallua N.
    Journal: Handchir Mikrochir Plast Chir; 2008 Apr; 40(2):105-9. PubMed ID: 18437669.
    Abstract:
    Merkel cell carcinoma (MCC) is a cutaneous, neuroendocrine tumour of high malignancy that is described as a firm, purple tumour localised in the dermal layer. Due to its high progression rate, the 5-year survival rate is quoted as between 30 and 74 %. The course of disease is characterised by high relapse rate (30 - 77 %) and lymph node metastases (ca. 50 %). Therapy of MCC is based on a radical surgical excision combined with sentinel lymph node biopsy (stadium I), lymph node dissection (stadium II) and postoperative radiotherapy. We report three cases of MCC under immunosuppression and present therapeutic options of MCC in overview.
    [Abstract] [Full Text] [Related] [New Search]